Depo Provera Leads
Reach women who developed meningioma or other intracranial tumors after receiving medroxyprogesterone acetate (Depo Provera) injections for contraception.
Depo Provera Litigation
Depo Provera is an injectable contraceptive containing medroxyprogesterone acetate, manufactured by Pfizer. Recent studies have established a strong association between prolonged Depo Provera use and an increased risk of developing meningioma, a type of brain tumor that forms on the membranes surrounding the brain and spinal cord. Lawsuits allege the manufacturer knew or should have known about this risk and failed to provide adequate warnings to patients and healthcare providers.
Associated Conditions
- Meningioma (brain tumors)
- Intracranial tumors
- Headaches and vision changes
- Seizures
- Neurological impairment
- Surgical intervention for tumor removal
- Hearing loss or cognitive decline
Claimant Eligibility
- Received Depo Provera injections for one year or longer
- Diagnosed with meningioma or intracranial tumor
- Tumor diagnosis occurred during or after Depo Provera use
- Required surgery, radiation, or ongoing monitoring for the tumor
- Medical records confirming Depo Provera prescription history
Why Law Firms Choose Us
Exclusive Leads
Every lead is yours alone. We never resell or share claimant information with competing firms, guaranteeing you first-mover advantage on every case.
Pre-Qualified Claimants
Our intake specialists screen every potential claimant against your specific case criteria before delivery, so your team only speaks with viable cases.
Live Transfer
Qualified claimants are transferred directly to your intake team in real time, maximizing conversion rates and reducing time-to-retainer.
Running a Depo Provera mass tort marketing campaign
Common questions from law firms about Depo Provera lead generation and campaign management.
- What does a Depo Provera mass tort marketing campaign include?
- A Depo Provera mass tort marketing campaign from Mass Tort Marketing Agency covers channel strategy across Meta, Google/PPC, OTT, and mass tort SEO; compliant ad creative; TCPA-verified intake; claimant qualification against your Depo Provera case criteria; and signed-retainer reporting. Performance is measured on cost per signed retainer, not raw lead volume.
- Are Depo Provera leads exclusive to my firm?
- Yes. Every Depo Provera lead is delivered to one firm only — never resold, syndicated, or shared with competing firms. Your firm owns the contact data, consent records, and call recordings.
- How are Depo Provera claimants qualified before delivery?
- Each Depo Provera claimant is screened against tort-specific facts (exposure windows, injury markers, and state eligibility) and carries a TrustedForm or Jornaya consent token captured under the FCC one-to-one consent standard before the lead reaches your intake team.
- How is a Depo Provera campaign priced?
- Campaigns are quoted and reported on cost per signed retainer (CPSR), so spend ties directly to signed cases rather than lead count. You can scale volume up or down by tort as your docket capacity changes.
See how every lead is qualified on our mass tort leads page, or compare providers in our top mass tort marketing firms guide.